STOCK BASED COMPENSATIONS (Details 2) |
9 Months Ended |
|---|---|
|
Dec. 31, 2020
USD ($)
shares
| |
| STOCK-BASED COMPENSATION | |
| Restricted stock outstanding, beginning | shares | 2,275,000 |
| Restricted stock granted | shares | 15,000 |
| Restricted stock vested | shares | 2,275,000 |
| Restricted stock outstanding, ending | shares | 15,000 |
| Weighted average fair value, beginning balance | $ 4,777,000 |
| Weighted average exercise price granted | 775,000 |
| Weighted average exercise price vested | 4,777,000 |
| Weighted average exercise price forfeited/cancelled/expired | 0 |
| Weighted average fair value, ending balance | $ 775,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to r No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|